Courthouse

3M Bair Hugger Surgical Blanket Lawsuits Consolidated into MDL

Seventy lawsuits filed against 3M Company and its subsidiary Arizant Healthcare, Inc., over infections allegedly caused by the companies’ post-surgical warming blanket, have been consolidated into a multidistrict litigation (MDL) under U.S. District Judge Joan N. Ericksen. Nine cases were filed in Minnesota; five cases were filed in Alabama, Arkansas, Kansas, Ohio, and Texas; and […]

Continue Reading

FDA Reclassifies Surgical Mesh as High-Risk Product

Yesterday, the U.S. Food and Drug Administration (FDA) reclassified surgical mesh for transvaginal repair of pelvic organ prolapse (POP) from a moderate-risk device (class II) to a high-risk device (class III). Additionally, the FDA gave the manufacturers final orders, stating that they had 30 months to prove that their products are safe and effective. The […]

Continue Reading

Can I file a claim for nursing malpractice?

In most cases, when a patient is injured as a result of nursing malpractice, it is not the nurse that will personally be held liable, but rather the hospital or clinic that employs her. There are laws in place that automatically apportion employees’ liability onto their employers. Therefore, when you file medical or nursing malpractice […]

Continue Reading

Local Law Firm Helps Feed Needy LI Families

Once again the Suffolk County Police and the New York State Police departments are teaming up to help feed needy families during the holiday season by giving free hams and turkeys. The 8th Annual “Cops Who Care” Food Drive is planned for December 22, 2015 between 1-2pm at 1st Baptist Church in Bay Shore. The […]

Continue Reading

Onglyza Linked to Heart Failure, Pancreatic Cancer, and Even Death

Onglyza is the latest diabetes drug to cause some concern amongst the U.S. Food and Drug Administration (FDA), joining other troubled diabetes medications such as Actos, Januvia, and Janumet, to name a few. Recently, an FDA advisory committee raised a red flag regarding the dipeptidyl peptidase-4 (DPP-4) inhibitor Onglyza. Onglyza (saxagliptin) was approved to treat […]

Continue Reading